Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/OptimizeRx Corporation/ 10-K

Annual Report · 10-K

OptimizeRx Corporation

OPRXNASDAQEQUITYCurrent

Annual Report

Filed Mar 12, 2026Accepted Mar 12, 2026, 4:03 PM EDTCIK 1448431Accession 0001448431-26-000005
View company →Permanent SEC source ↗
Share

Company context

OptimizeRx is a leading healthcare technology company that’s redefining how life science brands connect with patients and healthcare providers. Our platform combines innovative artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.

Current securities

OPRXNASDAQ · EQUITY · Current

Recent company filings

  1. 4 filingAug 24, 2026
  2. 4 filingAug 24, 2026
  3. S-8 filingAug 20, 2026
  4. 10-Q filingAug 13, 2026
  5. Results of Operations and Financial Condition · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureAug 12, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗